AR227567A1 - Procedimiento para la produccion de nuevos derivados de 2-(4-aminoalcoxi-fenil)-3,4-dihidro-quinazolin-4-onas y 2-(4-aminoalcoxi-fenil)-3,4-dihidro-pirido(2,3-e)pirimidin-4-onas - Google Patents

Procedimiento para la produccion de nuevos derivados de 2-(4-aminoalcoxi-fenil)-3,4-dihidro-quinazolin-4-onas y 2-(4-aminoalcoxi-fenil)-3,4-dihidro-pirido(2,3-e)pirimidin-4-onas

Info

Publication number
AR227567A1
AR227567A1 AR287776A AR28777681A AR227567A1 AR 227567 A1 AR227567 A1 AR 227567A1 AR 287776 A AR287776 A AR 287776A AR 28777681 A AR28777681 A AR 28777681A AR 227567 A1 AR227567 A1 AR 227567A1
Authority
AR
Argentina
Prior art keywords
aminoalcoxi
dihidro
fenil
onas
pirido
Prior art date
Application number
AR287776A
Other languages
English (en)
Spanish (es)
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19803046871 external-priority patent/DE3046871A1/de
Priority claimed from DE19813115447 external-priority patent/DE3115447A1/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Application granted granted Critical
Publication of AR227567A1 publication Critical patent/AR227567A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
AR287776A 1980-12-12 1981-12-11 Procedimiento para la produccion de nuevos derivados de 2-(4-aminoalcoxi-fenil)-3,4-dihidro-quinazolin-4-onas y 2-(4-aminoalcoxi-fenil)-3,4-dihidro-pirido(2,3-e)pirimidin-4-onas AR227567A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803046871 DE3046871A1 (de) 1980-12-12 1980-12-12 Neue chinazolinone, ihre herstellung und ihre verwendung als arzneimittel
DE19813115447 DE3115447A1 (de) 1981-04-16 1981-04-16 Neue pyrimidinone, ihre herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
AR227567A1 true AR227567A1 (es) 1982-11-15

Family

ID=25789685

Family Applications (1)

Application Number Title Priority Date Filing Date
AR287776A AR227567A1 (es) 1980-12-12 1981-12-11 Procedimiento para la produccion de nuevos derivados de 2-(4-aminoalcoxi-fenil)-3,4-dihidro-quinazolin-4-onas y 2-(4-aminoalcoxi-fenil)-3,4-dihidro-pirido(2,3-e)pirimidin-4-onas

Country Status (22)

Country Link
US (1) US4379788A (cs)
EP (1) EP0054132B1 (cs)
AR (1) AR227567A1 (cs)
AU (1) AU543568B2 (cs)
CA (1) CA1217767A (cs)
CS (1) CS227024B2 (cs)
DD (1) DD208151A5 (cs)
DE (1) DE3166627D1 (cs)
DK (1) DK525481A (cs)
ES (2) ES507761A0 (cs)
FI (1) FI813971A7 (cs)
GB (1) GB2090249B (cs)
GR (1) GR76952B (cs)
HU (1) HU187384B (cs)
IL (1) IL64504A (cs)
MY (1) MY8700562A (cs)
NO (1) NO814239L (cs)
NZ (1) NZ199254A (cs)
PH (1) PH18930A (cs)
PL (1) PL135330B1 (cs)
PT (1) PT74116B (cs)
SU (1) SU1056900A3 (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460589A (en) * 1980-10-03 1984-07-17 The Upjohn Company Process for treating hypertension
US4379778A (en) * 1980-10-10 1983-04-12 Air Products And Chemicals, Inc. Hydrogen peroxide synthesis
DE3428476A1 (de) * 1984-08-02 1986-02-13 Basf Ag, 6700 Ludwigshafen 4h-pyrido(2,3-d)(1,3)oxazin-4-on-derivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
DE3631294A1 (de) * 1986-09-13 1988-03-24 Thomae Gmbh Dr K Neue synergistische kombination bestehend aus einem phosphodiesterase-hemmer und einem thromboxan-a(pfeil abwaerts)2(pfeil abwaerts)-antagonisten und deren verwendung bzw. herstellung
US5037980A (en) * 1988-04-18 1991-08-06 American Cyanamid Company Phenyl imidazo[1,2-a]pyrimidines
GB8928346D0 (en) * 1989-12-15 1990-02-21 Smith Kline French Lab Chemical compounds
GB9126260D0 (en) * 1991-12-11 1992-02-12 Pfizer Ltd Therapeutic agents
GB9404485D0 (en) * 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues
SK287161B6 (sk) * 1997-11-12 2010-02-08 Bayer Healthcare Ag 2-Fenylsubstituované imidazotriazinóny, spôsob ich výroby, liečivá obsahujúce tieto látky a ich použitie
RU2207337C2 (ru) * 1998-11-18 2003-06-27 Изаксон Елена Александровна 6-(3-ацетилфенил)аминоурацил
US20040102324A1 (en) 2002-02-28 2004-05-27 Annis Gary David Heterocyclic diamide invertebrate pest control agents
US6642244B2 (en) 2001-03-16 2003-11-04 Bristol-Myers Squibb Co. Pyrazolopyridopyrimidine inhibitors of cGMP phosphodiesterase
US7893071B2 (en) * 2001-04-23 2011-02-22 University Of Virginia Patent Foundation Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic
BR0209541A (pt) * 2001-05-09 2004-04-20 Bayer Healthcare Ag Uso das imidazotriazinonas 2-fenil-substituìdas
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
CN1893951A (zh) * 2003-12-19 2007-01-10 默克公司 有丝分裂驱动蛋白抑制剂
SE0401345D0 (sv) * 2004-05-25 2004-05-25 Astrazeneca Ab Therapeutic compounds: Pyridine as scaffold
SE0401342D0 (sv) * 2004-05-25 2004-05-25 Astrazeneca Ab Therapeutic compounds
WO2005115993A1 (ja) 2004-05-31 2005-12-08 Banyu Pharmaceutical Co., Ltd. キナゾリン誘導体
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
AU2006299232A1 (en) * 2005-09-29 2007-04-12 Bayer Schering Pharma Aktiengesellschaft PDE inhibitors and combinations thereof for the treatment of urological disorders
WO2008041118A2 (en) * 2006-10-04 2008-04-10 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
WO2008151734A1 (en) * 2007-06-13 2008-12-18 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
CN101531638B (zh) * 2008-03-13 2011-12-28 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
CN102098918A (zh) * 2008-05-13 2011-06-15 帕纳德制药公司 用于治疗癌症和神经退行性疾病的生物活性化合物
CN101628913B (zh) 2008-07-18 2013-01-23 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
BR112015006524A8 (pt) * 2012-09-26 2019-08-20 Merck Patent Gmbh derivados de quinazolinona como inibidores de parp, seu processo de preparação, seu uso, medicamentos e conjunto (kit)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265697A (en) * 1964-09-04 1966-08-09 Shulton Inc 2-p-dialkylaminoalkoxyphenyl-2, 3-dihydro-4 (1h)-quinazolinones and their derivatives
DE1939109A1 (de) * 1968-08-31 1970-03-05 Troponwerke Dinklage & Co 2-Methyl-3-[2-(2-diaethylaminoaethoxy)-phenyl]-chinazolinon-(4) und Verfahren zu seiner Herstellung
US3862191A (en) * 1972-09-27 1975-01-21 Pfizer Pyrido{8 2,3-d{9 pyrimidin-4(3H)-one

Also Published As

Publication number Publication date
IL64504A0 (en) 1982-03-31
IL64504A (en) 1985-02-28
HU187384B (en) 1985-12-28
CS227024B2 (en) 1984-04-16
PL135330B1 (en) 1985-10-31
DE3166627D1 (en) 1984-11-15
ES8207156A1 (es) 1982-09-01
ES507761A0 (es) 1982-09-01
PT74116A (de) 1982-01-01
AU7847381A (en) 1982-06-17
GB2090249B (en) 1984-08-22
FI813971L (fi) 1982-06-13
FI813971A7 (fi) 1982-06-13
SU1056900A3 (ru) 1983-11-23
ES511835A0 (es) 1983-02-16
GB2090249A (en) 1982-07-07
CA1217767A (en) 1987-02-10
ES8304096A1 (es) 1983-02-16
US4379788A (en) 1983-04-12
DK525481A (da) 1982-06-13
DD208151A5 (de) 1984-03-28
MY8700562A (en) 1987-12-31
PT74116B (de) 1983-12-19
NZ199254A (en) 1985-02-28
NO814239L (no) 1982-06-14
AU543568B2 (en) 1985-04-26
GR76952B (cs) 1984-09-04
PH18930A (en) 1985-11-11
PL234175A1 (cs) 1982-08-16
EP0054132B1 (de) 1984-10-10
EP0054132A1 (de) 1982-06-23

Similar Documents

Publication Publication Date Title
AR227567A1 (es) Procedimiento para la produccion de nuevos derivados de 2-(4-aminoalcoxi-fenil)-3,4-dihidro-quinazolin-4-onas y 2-(4-aminoalcoxi-fenil)-3,4-dihidro-pirido(2,3-e)pirimidin-4-onas
AR231130A1 (es) Procedimiento para la produccion de nuevos derivados de n-benzoazepinalquil-n-fenilalquil-amina
MX6980E (es) Procedimiento para la produccion de derivados de carboestirilo
ES527986A0 (es) Procedimiento para la produccion de derivados de 1-azolil-2-aril-3-fluoro-alcan-2-ol.
ES520180A0 (es) Procedimiento para la preparacion de nuevos derivados de la aminometil-5-aril-3-oxazolidinona-2.
ES556927A0 (es) Procedimiento para la produccion de derivados de la 13-betamilbemicina
ES524976A0 (es) Procedimiento para la preparacion de nuevos derivados piperidinicos, piperacinicos y homopiperacinicos.
ES520089A0 (es) Procedimiento para la fabricacion de nuevos derivados arilicos de la piperacina.
ES510888A0 (es) "procedimiento para la produccion de derivados de 1-aril-2-azolileteno".
ES549587A0 (es) Procedimiento para la fabricacion de nuevos derivados nu- cleosidos
ES529774A0 (es) Procedimiento para la produccion de derivados de 1-sulfo-2-oxoacetidina
AR230437A1 (es) Procedimiento para la fabricacion de derivados de 2-(dialquamino,pirrolidinil o piperidinil)-alquil-tio-quinolina
ES523804A0 (es) Un procedimiento para la preparacion de nuevos derivados de propanolamina.
ES518518A0 (es) Procedimiento para la fabricacion de nuevos derivados aminoalcoxi aromaticos.
AR228161A1 (es) Procedimiento para desintegrar derivados de 2,4-dihidroxi-6-amino-s-triazina
ES517295A0 (es) Un procedimiento para la preparacion de nuevos derivados de propanolamina.
ES527985A0 (es) Procedimiento para la produccion de derivados de 1-fluoro-1-ariloxi-3-azolilmetil-2-alcanol.
AR230447A1 (es) Procedimiento para la preparacion de nuevos derivados sustituidos de 3,7-diazabiciclo-3,3,1-nonano,y procedimiento para la preparacion de las sustancias iniciales para dicho procedimiento
ES540173A0 (es) Procedimiento para la obtencion de nuevos 1,3,2-dioxaborina-nos
ES513169A0 (es) Procedimiento para la obtencion de nuevos derivados de benzazol.
ES513385A0 (es) "procedimiento para la fabricacion de derivados de la quinolina".
AR227793A1 (es) Procedimiento para la produccion de derivados de 1,4-dioxido de 2-alpha-de derivados de 1,4-dioxido de 2-(alpha-hidrazino-alpha-hidroximetil)-quinoxalina
AR228166A1 (es) Procedimiento para la fabricacion de derivados de 5,6,7,7a-tetrahidro-4h-tieno(3,2-c)-fenilalquil-5-piridin-2-ona
ES516787A0 (es) "procedimiento para la fabricacion de derivados de 5-aminoisoxazol".
ES518858A0 (es) Procedimiento para la fabricacion de derivados de tetrahidrobenzotiazol.